Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma

Head and Neck

Volumn 31, Issue 10, 2009, Pages 1335-1340

  Pérez, Itxaro ^a   Varona, Adolfo ^a   Blanco, Lorena ^a   Gil, Javier ^a   Santaolalla, Francisco ^a,b   Zabala, Aitor ^a   Ibarguen, Agustin Martínez ^a,b   Irazusta, Jon ^a   Larrinaga, Gorka ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

Author keywords

Angiotensin; APA; Asp AP; CD13; HNSCC; Peptidase; Tumor markers

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DIPEPTIDYL PEPTIDASE IV; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD13; CARCINOMA, SQUAMOUS CELL; FEMALE; GLUTAMYL AMINOPEPTIDASE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED;

EID: 70349331392     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21099     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:712-717.
3. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998;82: 1367-1375. (Pubitemid 28155400)
4. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002;21:7435-7451.
5. Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice DH. Molecular pathology of head and neck cancer. Histol Histopathol 2002;17:909-914. (Pubitemid 34784674)
6. Hallberg M, Le Grevès P, and Nyberg F. Neuropeptide processing. In: Lendeckel U, Hooper NM, editors. Proteases in the brain. New York: Springer Science and Business Media; 2004. pp 203-234.
7. Sekine K, Fujii H, Abe F, Nishikawa K. Augmentation of dead ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Int J Cancer 2001;94:485-491.
8. Vetro JA, Dummitt B, Chang Y-H. Methionine-aminopeptidase: emerging role in angiogenesis. In: Hooper NM, U Lendeckel, editors. Aminopeptidases in biology and disease. New York: Kluwer Academic/Plenum Press. 2004. pp 17-44.
9. Antczak C, De Meester I, Bauvois B. Ectopeptidases in pathophysiology. Bioessays 2001;23:251-260.
10. Carl-McGrath S, Lendeckel U, Ebert M, Röcken C. Ectopeptidases in tumour biology: a review. Histol Histopathol 2006;21:1339-1353.
11. Rosenthal EL, Matrisian LM. Matrix metalloproteinases in head and neck cancer. Head Neck 2006;28:639-648. (Pubitemid 44025114)
12. Scurry WC, Stack BC. Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma. Head Neck 2006;29:1144-1155.
13. Mantle D, Lauffart B, McDermott J, Gibson A. Characterization of aminopeptidases in human kidney soluble fraction. Clin Chim Acta 1990;187:105-113. (Pubitemid 20067297)
14. Silveira PF, Irazusta J, Gil J, Agirregoitia N, Casis L. Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase. Peptides 2001;22:2137-2144.
15. Florentin D, Sassi A, Roques BP. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem 1984;141:62-69.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
17. Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS, Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 2003;532:91-107.
18. Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001;3:459-468. (Pubitemid 33151012)
19. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E. Matrix metalloproteinase-2 and -9 activites correlate with the disease free survival of oral squuamous cell carcinoma patients. Int J Oncol 2002;20:189-194.
20. Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, Rechberger T, Golabek W. Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer. Otolaryngol Head Neck Surg 2003;128:132-136. (Pubitemid 36246131)
21. Varona A, Blanco L, López JI, et al. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. Am J Physiol-Renal Physiol 2007;292:780-788. (Pubitemid 46220546)
22. Larrinaga G, Lopez JI, Casis L, et al. Cystinyl aminopeptidase activity is decreased in renal cell carcinomas. Regul Pept 2007;144:56-61. (Pubitemid 350030299)
23. Blanco L, Larrinaga G, Pérez I, et al. Acid, basic and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma. Am J Physiol-Renal Physiol 2008;294:850-858.
24. Nanus DM. Of peptides and peptidases: the role of cell surface peptidases in cancer. Clin Cancer Res 2003; 15:6307-6309. (Pubitemid 38031813)
25. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981;68:932-941. (Pubitemid 11023521)
26. Petrovic N, Schacke W, Shapiro LH. CD13/Aminopeptidase N in tumor growth and angiogenesis. In: Hooper NM, Lendeckel U, editors. Aminopeptidases in biology and disease. New York: Kluwer Academic/Plenum Press. 2004. pp 179-200.
27. Luan Y, Xu W. The structure and main functions of aminopeptidase N. Curr Med Chem 2007;14:639-647.
28. Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993;54:137-143. (Pubitemid 23137011)
29. Fujii H, Nakajima M, Saiki I, et al. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 1993;13: 337-344.
30. Murakami H, Yokoyama A, Kondo K, Nakanishi S, Kohno N, Miyake M. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer. Clin Cancer Res 2003; 11:8674-8679.
31. Tokuhara T, Hattori N, Ishida H, et al. Clinical significance of aminopeptidase N in non-small cell lung cancer. Clin Cancer Res 2006;12:3971-3978. (Pubitemid 44078082)
32. Ichinose Y, Genka K, Koike T, et al. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst 2003;95:605-610. (Pubitemid 36553507)
33. Wilk S, Wilk E, Magnusson RP. Purification, characterization and cloning of a cytosolic aspartyl aminopeptidase. J Biol Chem 1998;273:15961-15970. (Pubitemid 28311361)
34. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer?. Trends Endocrinol Metab 2005;16:293-299. (Pubitemid 41206635)
35. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-184.
36. Van deer Knaap R, Siemens C, Coebergh JW, Van Dujin CM, Hofman A, Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam study. Cancer 2008;112:748-757.
37. Yasumatsu R, Nakashima T, Masuda M, et al. Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 2004;130:567-573. (Pubitemid 39371327)
38. Nanus DM, Bogenrieder T, Papandreou CN, et al. Aminopeptidase A expression and enzymatic activity in primary human renal cancers. Int J Oncol 1998;13:261-267. (Pubitemid 28329213)
39. Martínez JM, Prieto I, Ramírez MJ, Cueva C, Alba F, Martínez M. Aminopeptidase activities in breast cancer tissue. Clin Chem 1999;45:1797-1802. (Pubitemid 29477338)
40. Ino K, Uehara C, Kikkawa F, et al. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 2003;88:3973-3982. (Pubitemid 37034554)
41. Suganuma T, Ino K, Shibata K, et al. Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor. Lab Invest 2004;84:639-648. (Pubitemid 38858473)
42. Ino K, Shibata K, Kajiyama H, Kikkawa F, Mizutani S. Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. Biol Chem 2004; 385:683-690. (Pubitemid 39255627)
43. Re RN, Cook JL. The intracrine hypothesis: An update. Regul Pept 2006;133:1-9.
44. Baker KM, Chernin MI, Schreiber T, et al. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 2004;36:75-90. (Pubitemid 38726186)